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1. Introduction
Saliva is a multi-constituent oral fluid and is considered a mirror of the body’s 
health. The science of saliva has advanced exponentially in the past decade. Saliva 
and its constituents are being increasingly used for surveillance in various human 
diseases. The ability to assess the role of salivary components as potential biomark-
ers is a recent development with increased interest in its use as a diagnostic and 
prognostic tool [1]. The availability of newer and sensitive technologies has enabled 
the identification of potential biomarkers even when present in small quantities, 
thereby signifying the use of saliva as an important assessment media [2].
Salivary diagnostics is an important and significant development in disease diag-
nosis and treatment delivery. The need for diagnosis of oral and systemic disease and 
monitoring health regularly is the need of the hour, and saliva owing to its nonin-
vasive and ease of collection along with the ability to detect a myriad of biomarkers 
is a promising tool. Salivary analytes have been evaluated for their role as potential 
biomarker in dental caries, periodontal diseases, oral microbial infections such as 
HIV, autoimmune disorders such as Sjogren’s syndrome, drug and hormone moni-
toring, as well as in diagnosis of systemic diseases. Additionally, salivary diagnostics 
is emerging as an important investigation in the identification of tumor-specific 
biomarkers for early detection, diagnosis, prognosis, and therapeutic interventions 
of oral and oropharyngeal cancers as well as in cancer of distant sites like breast, 
prostate, cervical, and ovarian cancer. Research is being increasingly undertaken 
to identify saliva-based biomarkers which either singly or as a panel could be of 
significant use. Once these biomarkers are quantified and validated, they can be of 
use in point-of-care diagnostics for chairside detection of various human diseases.
A thorough knowledge of the functions and properties of saliva, its role in 
health and disease, and the diagnostic technologies available for the identification 
of saliva biomarkers is of paramount importance to further the knowledge on their 
usefulness in clinical research and patient management. This formed the basis 
of the current book on saliva which could serve as an important guide for future 
research involving salivary diagnostics.
The scientific literature on using saliva as a diagnostic tool begin to emerge since 
the 1960s. Earlier attempts on the use of salivary diagnostics were confusing owing 
to the lack of uniformity in the methodology of salivary analysis and the use of 
available instrumentation. Over a period, the ability to determine salivary compo-
nents has achieved a sense of uniformity and precision which could be attributed to 
the understanding of methods of handling saliva samples in various investigating 
laboratories. The chapters of this book attempt to highlight the advancements of 
salivary diagnostics over the years, the identification of various salivary-based 
biomarkers in oral and systemic diseases as evident in the literature, and the future 
considerations in employing saliva as a diagnostic tool.
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The book intends to provide an overview of salivary constituents; the functions 
of saliva; the role of salivary diagnostics in various oral diseases, oral cancer, and 
breast cancer; and the determination of salivary DNA for forensic analysis.
2. Saliva in health
Saliva is a complex fluid composed of 99.5% water and 0.5% solid material 
which is inclusive of organic and inorganic constituents. Whole saliva is composed 
of secretions from the major and minor salivary glands, gingival crevicular fluid, 
oral mucosal transudate, nasal and pharyngeal secretions, and desquamated 
epithelial cells. The functions of saliva include but not limited to lubrication, 
digestion, antimicrobial activity, buffering, and remineralization of tooth enamel. 
These functions are performed by the different components of saliva [3]. Numerous 
organic compounds such as proteins, antimicrobials, immunoglobulins, and blood 
group substances and various inorganic components are present in varying quanti-
ties in saliva [4]. The components of saliva are either an inherent component of 
saliva itself or are derived from blood. The component of plasma may enter into 
saliva through various processes like ultrafiltration through gap junctions, between 
cells of secretory units, transudation of plasma compounds into oral cavity through 
crevicular fluid, and by passive diffusion of lipophilic molecules [2]. The source 
of information in saliva is largely derived from the variety of DNA, RNA, and 
proteins present in saliva. Salivary DNA represents the genetic information of the 
hosting human body, the oral microbiota, and infecting DNA viruses. Salivary 
RNA provides information on transcription rates of the host genes as well as oral 
microbiota. Salivary proteins represent genetic information and help understand 
the translational regulation of the host body [5]. Cell-free saliva has been found to 
contain over 1000 proteins involved in a wide range of biological functions, mRNA 
and microRNA transcripts, and metabolites [6].
Specimen collection is an integral part of clinical research for identification and 
characterization of tumor-related biomarkers. Saliva can be collected under both 
resting and stimulated conditions. The duration of collecting period is important 
because flow rates vary with time. It is hence important to follow a standardized 
collection procedure during the whole sampling period to keep the secretion rate as 
constant as possible [7]. Further to collection of saliva, it is necessary for appropri-
ate storage of the sample before analysis. The collected saliva should be kept on 
ice, aliquoted, and frozen as soon as possible to maintain the sample integrity [8]. 
Certain approaches to store saliva to prevent degradation of salivary compounds 
include immediate storage without any processing; if analysis is to be done within 
30–90 min, saliva can be stored at room temperature; for analysis after 3–6 h after 
collection, storage is to be done at +4°C; and if analysis is done after days to months 
after collection, storage is to be done at −20°C or still better at −80°C [2].
The diagnostic techniques employed in the analysis of the processed saliva have 
made exponential progress over time. Previous techniques for analysis included 
calorimetric analysis, spectrophotometry, and few optical techniques. These meth-
ods have proven efficacy in serum/plasma analysis but did not find similar success 
in saliva. This could be attributed to the decreased concentration of the various 
analytes in saliva which demanded a more sensitive and specific technique to enable 
their identification. The application of liquid chromatography, gas chromatography, 
flow cytometry, and ELISA was successful in this regard. More recently several 
techniques such as nuclear magnetic spectroscopy and liquid chromatography 
coupled with mass spectrometry have been highly successful. Nuclear magnetic 
resonance spectroscopy enables the identification and simultaneous quantification 
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of a wide range of organic compounds in micromolar range [9]. The advantages 
of NMR spectroscopy are its high resolution, minimal sample preparation, and 
time-saving procedure [10]. Mass spectrometry is a method used to analyze samples 
either directly or following chromatographic or electrophoretic separation [11]. The 
coupling of liquid chromatography with spectrometry has enabled the identifica-
tion of low-abundance salivary metabolites with very high sensitivity [12].
3. Saliva as a diagnostic tool
The complex nature of saliva consisting of mixture of components has posed 
difficulties in identification of specific constituents. However, recent inroads made 
in the discovery of highly sensitive technologies have enabled the identification of 
salivary biomarkers with high precision even when present in minute quantities. 
The role of saliva as a diagnostic tool was evaluated in HIV, oral cancer, as well as in 
cancer of other sites to name a few.
The need for chairside diagnosis and personalized medicine has led to an 
increase in the use of fluid-based biomarkers in disease diagnosis and treatment 
planning. Research involved in identification of disease-specific biomarkers in 
the blood, urine, and other body fluids was not forthcoming. The lack of absolute 
success of serum biomarkers along with the improvement in saliva collection and 
testing presents a unique opportunity for salivary diagnostics.
Molecular alterations are usually attributed to the inherent biological properties 
of human cell which may contribute to the disease progression. Identification of 
these alterations can assist in early detection and prediction of prognosis of vari-
ous diseases including cancer. A comprehensive approach is based on a detection 
of panel of molecular alteration which can serve as an ideal biomarker for specific 
diseases. The rapid advancements in the identification of these molecular targets 
have something to do with the evolution of “omics” group of diagnostic aids [13]. 
Omics are scientific disciplines constituting the study of related sets of biological 
molecules. These include genomics, epigenomics, proteomics, transcriptomics, 
and metabolomics. The term “salivaomics” was coined in 2008 to reflect the rapid 
development of knowledge about the various omics constituents of saliva [14]. The 
substantiation of salivaomics technology has led to the discovery, validation, and 
application of salivary biomarkers in early diagnosis, treatment planning, and pre-
diction of prognosis. Additionally, the development of bioinformatics and statisti-
cal tools aids in determining the discriminatory biomarkers in saliva for various oral 
and systemic diseases [14].
4. Salivaomics
Salivary diagnostics are being extensively reviewed to identify potential bio-
markers using these omics technologies [6]. Ever since its discovery, metabolomic 
investigations can generate quantitative data for metabolites which offers a promis-
ing clinical strategy to characterize the association between salivary analytes and a 
disease [1].
Genomics defines the genetic message and the resulting protein sequences 
[15]. Genomic analysis in saliva includes the identification of disease-specific 
characteristics such as somatic mutations in tumor suppressor genes or oncogenes, 
microsatellite alterations, abnormal protein methylation, and mitochondrial DNA 
alteration [16]. The proteome represents the complete set of proteins encoded by 
the genome. Proteomics is the study of proteome that identifies the cellular levels 
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of all the isoforms and posttranslational modifications of the various proteins 
that are encoded by the genome of the cell under a given set of circumstances [5]. 
Salivary transcriptomics is defined as the study of the expressed mRNA transcript 
complement of a cell under different conditions. The large panel of human mRNA 
is determined using microarray technology followed by validation [17].
Metabolomics is one of the core disciplines of systems biology focusing on the 
study of low molecular weight organic and inorganic chemicals in biological system 
[18]. Metabolomics describes the full repertoire of small molecules present in cells, 
tissues, organs, and biological fluids [6]. The metabolomic profiles can be altered by 
various pathological processes, and global changes in these profiles may indicate the 
presence of a disease.
These form the diagnostic alphabets of saliva, and their discovery and quantifi-
cation have resulted in the application of salivary diagnostics in clinical practice, in 
point-of-care diagnostics, as well as in personalized medicine.
5. Conclusion
Salivary biomarkers represent an accurate, noninvasive approach for detection 
of oral and systemic diseases and an attractive area of research. The development of 
robust and sensitive techniques for detection of salivary biomarkers, its quantifica-
tion, and validation further maturing to clinical use is the need of the hour. There 
has been an upsurge in the laboratory-based tests for detection of salivary biomark-
ers which are ready for definitive validation through the use of various prospective 
clinical study designs. Researchers can now attempt to develop salivary biomarkers 
for early detection of diseases employing the omics constituents, saliva-based 
bioinformatics, and statistical tools. It is worth noting that the technology available 
enables one to detect promising and new salivary biomarkers as stand-alone tools 
without relying on their initial identification in the blood and other bodily fluids.
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